Logo

Yas Holding Collaborates with Alvogen to Commercialize its Generic Portfolio in MENA Region

Share this
Yas Holding Collaborates with Alvogen to Commercialize its Generic Portfolio in MENA Region

Yas Holding Collaborates with Alvogen to Commercialize its Generic Portfolio in MENA Region

Shots:

  • Yas Holding entered into an exclusive license and distribution agreement with Alvogen to commercialize its targeted generic pharmaceuticals portfolio in MENA region
  • The collaboration will expand Alvogen’s presence in the MENA region including Gulf- KSA- Levant- North Africa and Sub-Saharan Africa and will improve clinical outcomes and QoL of patients in the MENA region
  • Alvogen’s generic portfolio comprises of 28 products for oncology- autoimmune- inflammation and blood diseases and will be commercialized from 2020

Click here to­ read full press release/ article | Ref: Alvogen | Image: Alvogen


Tuba

Tuba was Senior Editor at PharmaShots. She was curious, creative, and passionate about recent updates and innovations in the life sciences industry. She covered Biopharma, MedTech, and Digital health segments. Tuba also had an experience in digital and social media marketing and ran the campaigns independently. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions